中华糖尿病杂志
中華糖尿病雜誌
중화당뇨병잡지
CHINES JOURNAL OF DLABETES MELLITUS
2014年
7期
520-523
,共4页
王芳%高婧%阎胜利%赵世华%余霄龙%陈颖%赵文娟%王娈%王颜刚
王芳%高婧%閻勝利%趙世華%餘霄龍%陳穎%趙文娟%王孌%王顏剛
왕방%고청%염성리%조세화%여소룡%진영%조문연%왕련%왕안강
糖尿病,2型%家族史%胰岛素%第一时相分泌%左旋精氨酸
糖尿病,2型%傢族史%胰島素%第一時相分泌%左鏇精氨痠
당뇨병,2형%가족사%이도소%제일시상분비%좌선정안산
Diabetes mellitus,type 2%Family,history%Insulin%First phase function%L-arginine
目的:观察有或无糖尿病家族史的初诊2型糖尿病(T2DM)患者胰岛素泵强化治疗前后胰岛素第一时相分泌功能的变化,探讨遗传背景对早期胰岛素分泌功能的影响。方法选取2008年7月1日至2011年12月1日初诊T2DM患者158例,其中有家族史组(FH+DM)81例,无家族史组(FH-DM)77例,分别给予胰岛素泵治疗10 d,于治疗前和停泵2 d后用左旋精氨酸(L-ARG)刺激法测胰岛素值。两组间比较采用t检验,多个变量间的分析采用多元逐步回归分析。结果(1)胰岛素分泌峰值:治疗前,FH+DM、FH-DM组胰岛素峰值倍数分别为5.0±2.5、5.2±2.5。强化治疗后,胰岛素峰值倍数分别增加了14.3%和16.1%。(2)胰岛素净分泌量:治疗前FH+DM组2 min胰岛素值和胰岛素第一时相净分泌量均明显低于FH-DM组。治疗后,两组胰岛素第一时相净分泌量分别为20.41 mU/L、22.39 mU/L( P<0.05);2组胰岛素第一时相净分泌量均较治疗前降低,分别降低了18.4%和20%。(3)稳态模型胰岛素抵抗指数:FH+DM组与FH-DM组患者治疗10 d后比治疗前降低(分别为4.26比2.02和5.14比2.15,均P<0.05)。结论胰岛素泵强化治疗对无家族史的初诊T2DM患者胰岛第一时相分泌功能改善作用更明显。
目的:觀察有或無糖尿病傢族史的初診2型糖尿病(T2DM)患者胰島素泵彊化治療前後胰島素第一時相分泌功能的變化,探討遺傳揹景對早期胰島素分泌功能的影響。方法選取2008年7月1日至2011年12月1日初診T2DM患者158例,其中有傢族史組(FH+DM)81例,無傢族史組(FH-DM)77例,分彆給予胰島素泵治療10 d,于治療前和停泵2 d後用左鏇精氨痠(L-ARG)刺激法測胰島素值。兩組間比較採用t檢驗,多箇變量間的分析採用多元逐步迴歸分析。結果(1)胰島素分泌峰值:治療前,FH+DM、FH-DM組胰島素峰值倍數分彆為5.0±2.5、5.2±2.5。彊化治療後,胰島素峰值倍數分彆增加瞭14.3%和16.1%。(2)胰島素淨分泌量:治療前FH+DM組2 min胰島素值和胰島素第一時相淨分泌量均明顯低于FH-DM組。治療後,兩組胰島素第一時相淨分泌量分彆為20.41 mU/L、22.39 mU/L( P<0.05);2組胰島素第一時相淨分泌量均較治療前降低,分彆降低瞭18.4%和20%。(3)穩態模型胰島素牴抗指數:FH+DM組與FH-DM組患者治療10 d後比治療前降低(分彆為4.26比2.02和5.14比2.15,均P<0.05)。結論胰島素泵彊化治療對無傢族史的初診T2DM患者胰島第一時相分泌功能改善作用更明顯。
목적:관찰유혹무당뇨병가족사적초진2형당뇨병(T2DM)환자이도소빙강화치료전후이도소제일시상분비공능적변화,탐토유전배경대조기이도소분비공능적영향。방법선취2008년7월1일지2011년12월1일초진T2DM환자158례,기중유가족사조(FH+DM)81례,무가족사조(FH-DM)77례,분별급여이도소빙치료10 d,우치료전화정빙2 d후용좌선정안산(L-ARG)자격법측이도소치。량조간비교채용t검험,다개변량간적분석채용다원축보회귀분석。결과(1)이도소분비봉치:치료전,FH+DM、FH-DM조이도소봉치배수분별위5.0±2.5、5.2±2.5。강화치료후,이도소봉치배수분별증가료14.3%화16.1%。(2)이도소정분비량:치료전FH+DM조2 min이도소치화이도소제일시상정분비량균명현저우FH-DM조。치료후,량조이도소제일시상정분비량분별위20.41 mU/L、22.39 mU/L( P<0.05);2조이도소제일시상정분비량균교치료전강저,분별강저료18.4%화20%。(3)은태모형이도소저항지수:FH+DM조여FH-DM조환자치료10 d후비치료전강저(분별위4.26비2.02화5.14비2.15,균P<0.05)。결론이도소빙강화치료대무가족사적초진T2DM환자이도제일시상분비공능개선작용경명현。
Objective To observe the different effects between patients with or without family history of diabetes with insulin pump therapy , and explore the genetic background of early insulin secretion function.Methods A total of 158 newly diagnosed type 2 diabetic patients from July 1st 2008 to December 1st 2011 were recruited.According to the presence or absence of family history of diabetes , they were divided into 2 group:one was with a family history group ( FH+DM group) and another was without a family history group(FH-DM group).All the patients were treated with continuous subcutaneous insulin infusion (CSII) for 10 days.L-arginine (L-ARG) stimulating test was used to test the insulin values before and after intensive insulin therapy.t test was used between 2 groups.Analysis of multiple variables using multiple regression analysis.Results ( 1 ) The peak of insulin secretion: before intensive insulin therapy , the multiples of the peak of the FH +DM group and FH-DM group were 5.0 ±2.5, 5.2 ±2.5, respectively.After the therapy , they were increased by 14.3% and 16.1%.( 2 ) The first phase of insulin secretion:before the therapy ,the level of 2 min insulin incretion and the first phase of insulin secretion in FH +DM group was lower than FH-DM.After the therapy , the level of first phase insulin secretion were 20.41 mU/L and 22.39 mU/L of the two groups.They were lowered by 18.4%and 20%,and FH-DM had a more obvious reduction.(3) HOMA-IR:HOMA-IR in the two groups were both lower than before.They were 4.26 vs 2.02,and 5.14 vs 2.15(P<0.05).Conclusion Insulin pump therapy has positive effects on the first phase function of islet β-cell.And the result is more obvious in the group without family history.